CTOs on the Move

AltPep

www.altpep.com

 
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world`s most intractable diseases: amyloid diseases. We are currently focusing on CNS disorders, in particular Alzheimer`s Disease (AD). We target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.altpep.com
  • 100 NE Northlake Way Suite 300
    Seattle, WA USA 98105
  • Phone: N/A

Executives

Name Title Contact Details

Funding

AltPep raised $23.1M on 01/12/2021

Similar Companies

Verax Biomedical Incorporated

Verax Biomedical Incorporated is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Dren Bio

Dren Bio is a San Carlos, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.

480 Biomedical

480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery.

Receptor Life Sciences

Receptor Life Sciences, Inc. develops inhaled therapeutic products for conditions including chronic pain, neurologic diseases, and inflammatory disorders.

Isoflex

Isoflex is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.